Long-term outcomes of pexidartinib in tenosynovial giant cell tumors期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Long-term outcomes of pexidartinib in tenosynovial giant cell tumors

Authors:	Hans Gelderblom MD Andrew J Wagner MD PhD William D Tap MD Emanuela Palmerini MD PhD Zev A Wainberg MD Jayesh Desai MBBS John H Healey MD Michiel A J van de Sande MD PhD Nicholas M Bernthal MD Eric L Staals MD PhD Charles G Peterfy MD PhD Anna Maria Frezza MD Henry H Hsu MD Qiang Wang PhD Dale E Shuster PhD Silvia Stacchiotti MD

Institution:	1. Leiden University Medical Center, Leiden, the Netherlands;2. Dana-Farber Cancer Institute, Boston, Massachusetts;3. Memorial Sloan Kettering Cancer Center, New York, New York Weill Cornell Medical College, New York, New York;4. IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy;5. David Geffen School of Medicine, University of California Los Angeles, Santa Monica, California;6. Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;7. Memorial Sloan Kettering Cancer Center, New York, New York;8. Spire Sciences, Inc, Boca Raton, Florida;9. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;10. Plexxikon, Berkeley, California;11. Daiichi Sankyo, Inc, Basking Ridge, New Jersey

Abstract:

Keywords:	efficacy long term pexidartinib pooled analysis safety tenosynovial giant cell tumor (TGCT) tumor response